We are live on ! Find out more
C

Chescapmanager Portfolio holdings

AUM $1.12B
1-Year Est. Return 67.49%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+67.49%
3 Year Est. Return
+215.18%
5 Year Est. Return
+141.46%
10 Year Est. Return
–
AUM
$785M
AUM Growth
+$142M
Cap. Flow
+$140M
Cap. Flow %
17.8%
Top 10 Hldgs %
59.77%
Holding
42
New
2
Increased
5
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
KBR icon
KBR
KBR
+$5.73M
2
DIS icon
Walt Disney
DIS
+$3.42M
3
FTI icon
TechnipFMC
FTI
+$2.08M
4
SNOW icon
Snowflake
SNOW
+$1.63M
5
TVRD
Tvardi Therapeutics
TVRD
+$263K

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$8.52M
2
UBER icon
Uber
UBER
+$7.6M
3
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$3.03M
4
AMZN icon
Amazon
AMZN
+$2.68M
5
VRT icon
Vertiv
VRT
+$659K

Sector Composition

Rank Sector Weight
1 Industrials 15.53%
2 Technology 14.49%
3 Consumer Discretionary 6.7%
4 Communication Services 5.66%
5 Consumer Staples 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
26
CALL
SLB Ltd
SLB
$76.5B
$7.29M 0.93%
125,000
– –
DAL icon
27
CALL
Delta Air Lines
DAL
$57B
$6.4M 0.82%
173,000
-77,000
-31% -$3.34M
OWL icon
28
Blue Owl Capital
OWL
$6.54B
$6M 0.76%
463,251
– –
LAZR
29
DELISTED
Luminar Technologies
LAZR
$5.46M 0.7%
79,936
– –
U icon
30
Unity
U
$13.3B
$5.4M 0.69%
172,099
– –
GRAB icon
31
Grab
GRAB
$13.7B
$4.78M 0.61%
1,351,173
-173,965
-11% -$621K
LAZR
32
CALL
DELISTED
Luminar Technologies
LAZR
$3.41M 0.43%
50,000
-13,333
-21% -$1.22M
UBER icon
33
Uber
UBER
$139B
$3.16M 0.4%
68,700
-166,300
-71% -$7.6M
TVRD
34
Tvardi Therapeutics
TVRD
$23.8M
$2.95M 0.38%
48,795
+2,807
+6% +$263K
TBPH icon
35
Theravance Biopharma
TBPH
$874M
$2.48M 0.32%
287,333
– –
DAL icon
36
Delta Air Lines
DAL
$57B
$1.85M 0.24%
50,000
– –
DNA icon
37
Ginkgo Bioworks
DNA
$487M
$793K 0.1%
10,957
– –
KROS icon
38
Keros Therapeutics
KROS
$202M
$322K 0.04%
10,105
– –
GRABW icon
39
Grab Holdings Warrant
GRABW
$520K
$34.5K ﹤0.01%
100,000
– –
DNA.WS
40
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$23.3K ﹤0.01%
103,521
– –
PRDS
41
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-1,672,379
Closed -$3.03M
1
2

Similar funds

CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Chescapmanager's Q3 2023 Portfolio in Review

As of Q3 2023, Chescapmanager held 42 positions worth $785M, up 22% from $643M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Chescapmanager deployed $140M of net new capital in Q3 2023, opening 2 new positions and adding to 5 existing holdings.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Activision Blizzard, an estimated $8.52M trimmed.

  • Chescapmanager added most to KBR in Q3 2023, an estimated $5.73M increase.
  • Chescapmanager's biggest Q3 2023 reduction was Activision Blizzard, cutting an estimated $8.52M.
  • Chescapmanager fully exited Pardes Biosciences, Inc. Common Stock in Q3 2023, selling an estimated $3.03M.
  • Chescapmanager's ten largest holdings make up 60% of its $785M portfolio in Q3 2023.
  • Chescapmanager opened 2 new positions and closed 1 in Q3 2023.
  • Chescapmanager's portfolio value rose 22% quarter-over-quarter to $785M.

Based on Chescapmanager's 13F filing for Q3 2023, filed 14 Nov 2023.